Core Viewpoint - The legal opinion letter from Beijing Wan Shang Tian Qin Law Firm confirms that the procedures for the convening and holding of Jiangsu Lanfeng Bio-chemical Co., Ltd.'s 2025 first extraordinary general meeting of shareholders comply with relevant laws and regulations [2][4][6]. Group 1: Meeting Procedures - The extraordinary general meeting was convened by the company's board of directors, with the decision made on July 28, 2025, to hold the meeting on August 15, 2025 [2][3]. - A notice regarding the meeting was published on July 30, 2025, detailing the convenor, meeting time, method, and other relevant matters [3]. - The meeting utilized a combination of on-site voting and online voting, with specific time slots allocated for each method [3]. Group 2: Attendance and Voting - A total of 132 shareholders and their representatives attended the meeting, representing 113,326,555 shares, which is 30.1978% of the total shares [4]. - Of the attendees, 8 were present at the on-site meeting, representing 107,278,555 shares (28.5862%), while 124 participated via online voting, representing 6,048,000 shares (1.6116%) [4]. - The voting results showed that the proposals were overwhelmingly approved, with significant majorities in favor [6][8]. Group 3: Voting Results - The first proposal received 73,537,532 votes in favor, accounting for 98.2788% of the votes cast [5]. - The second proposal was approved with 113,139,155 votes in favor, representing 99.8346% of the total votes [6]. - The third proposal also passed with 113,144,455 votes in favor, which is 99.8393% of the total votes [8]. Group 4: Conclusion - The law firm concluded that all aspects of the meeting, including the convening procedures, qualifications of attendees, and voting processes, were in compliance with legal and regulatory requirements, rendering the resolutions valid [6].
蓝丰生化: 北京市万商天勤律师事务所关于江苏蓝丰生物化工股份有限公司2025年第一次临时股东会的法律意见书